Home » Authors » Mark McCarty

Articles by Mark McCarty

FDA to roll out 'track-and-trace' for drugs; devices may follow

July 12, 2006

By Mark McCarty

Internet seen as conduit for best-practices dissemination

July 11, 2006

By Mark McCarty

Panel: U.S. universal coverage will come with less med-tech

July 10, 2006

By Mark McCarty

HSAs: fairly traditional coverage – or 'extra dollars for the rich'?

July 6, 2006

By Mark McCarty

Moratorium on Medicare cuts for imaging eyed in H.R. 5704

July 6, 2006

By Mark McCarty

New FDA guidances aimed at reducing 'gridlock' of trials

July 5, 2006

By Mark McCarty

Risk analysis role in ICD implantation decision is debated

July 1, 2006

By Mark McCarty

HSAs: fairly traditional coverage – or 'extra dollars for the rich'?

June 30, 2006

By Mark McCarty

FDA's Tillman says product lifecycle model is 'outdated'

June 29, 2006

By Mark McCarty

Hearing debates U.S. potential as payer for medical tourism

June 28, 2006

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...